Real-World Evidence Test of ACEMg for Sudden Hearing Loss or Sudden Deafness
If you experience a sudden loss of hearing, seek immediate medical attention from an Ear, Nose, and Throat (ENT) specialist. Early treatment can significantly improve the chances of recovery. Visit the NIDCD website for more information.
Sudden hearing loss or sudden deafness, known as sudden sensorineural hearing loss (SSNHL), is an emergency. Often, it has no identifiable cause. However, pathological processes underlying the condition are believed to include sudden reductions in cochlear blood flow, inflammation, and increased oxidative stress. These processes can lead to the rapid death of cochlear hair cells, which are essential for translating sound waves into neural signals.
The therapeutic potential of ACEMg in SSNHL is supported by its ability to:
- Mitigate Oxidative Stress: The biomedicine formula ACEMg is patented to act synergistically to reduce cochlear oxidative damage. This is particularly relevant in cases where SSNHL is suspected to result from sudden increases in oxidative stress, such as in viral or vascular incidents.
- Support Cochlear Blood Flow: Magnesium’s vasodilatory properties improve blood flow within the cochlea, countering ischemic events that could precipitate SSNHL. This improved circulation aids in the delivery of essential nutrients and the removal of metabolic byproducts.
If you or someone you know is experiencing SSNHL, please contact ssnhl@soundbites.com or text 734-277-3363 immediately with your U.S. mailing address to receive an expedited shipment. Then arrange for frequent otoacoustic emissions (OAE) examinations to monitor inner ear auditory function and potential recovery. For avoidance of doubt, this is your personal test. ACEMg is clinically proven to preserve or improve auditory function, but not clinically proven to restore auditory function after SSNHL. Case reports would be appreciated. Send your story to ssnhl@soundbites.com.